News
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...
7h
The Print on MSNIndia sees 20k bariatric surgeries a year. But blockbusters Mounjaro, Wegovy are shaking up obesity arenaIndia's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...
A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...
Dr Ducu Botoaca, who has a central London aesthetics clinic, told the MailOnline that he has seen a worrying increase in ...
New research reveals weight is swiftly regained after discontinuing anti-obesity medications like Ozempic, despite their ...
Explore more
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the.
The age-old advice to lose weight is to exercise and eat healthy, but what if you can’t work out regularly (or just don’t ...
Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...
Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results